| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.007 |